Literature DB >> 15685213

Activation of the nociceptin/orphanin FQ receptor reduces bronchoconstriction and microvascular leakage in a rabbit model of gastroesophageal reflux.

Bruno D'Agostino1, Giuseppina Marrocco, Marilisa De Nardo, Girolamo Calò, Remo Guerrini, Luca Gallelli, Charles Advenier, Francesco Rossi.   

Abstract

1. Nociceptin/orphanin FQ (N/OFQ) is the endogenous peptide ligand for a specific G-protein coupled receptor, the N/OFQ peptide receptor (NOP). The N/OFQ-NOP receptor system has been reported to play an important role in <span class="Disease">pain, <span class="Disease">anxiety and appetite regulation. In airways, N/OFQ was found to inhibit the release of tachykinins and the bronchoconstriction and cough provoked by capsaicin. 2. Here we evaluated the effects of NOP receptor activation in bronchoconstriction and airway microvascular leakage induced by intraesophageal (i.oe.) hydrochloric acid (HCl) instillation in rabbits. We also tested the effects of NOP receptor activation in SP-induced plasma extravasation and bronchoconstriction. 3. In anesthetized New Zealand rabbits bronchopulmonary function (total lung resistance (R(L)) and dynamic compliance (C(dyn))) and airway microvascular leakage (extravasation of Evans blue dye) were evaluated. 4. Infusion of i.oe. HCl (1 N) led to a significant increase in bronchoconstriction and plasma extravasation in the main bronchi and trachea of rabbits pretreated with propranolol, atropine and phosphoramidon. 5. Bronchoconstriction and airway microvascular leakage were inhibited by N/OFQ (3-30 microg kg(-1) i.v.) in a dose-dependent manner. The NOP receptor agonist [Arg14,Lys15]N/OFQ mimicked the inhibitory effect of N/OFQ, being 10-fold more potent, UFP-101, a peptide selective NOP receptor antagonist, blocked the inhibitory effects of both agonists. 6. Under the same experimental conditions, N/OFQ and [Arg14,Lys15]N/OFQ did not counteract the bronchoconstriction and airway microvascular leakage induced by substance P. 7. These results suggest that bronchoconstriction and airway plasma extravasation induced by i.oe. HCl instillation are inhibited by activation of prejunctional NOP receptors.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15685213      PMCID: PMC1576063          DOI: 10.1038/sj.bjp.0706066

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  62 in total

1.  Highly potent nociceptin analog containing the Arg-Lys triple repeat.

Authors:  K Okada; T Sujaku; Y Chuman; R Nakashima; T Nose; T Costa; Y Yamada; M Yokoyama; A Nagahisa; Y Shimohigashi
Journal:  Biochem Biophys Res Commun       Date:  2000-11-19       Impact factor: 3.575

2.  Substance P in the nucleus of the solitary tract augments bronchopulmonary C fiber reflex output.

Authors:  T Mutoh; A C Bonham; J P Joad
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2000-10       Impact factor: 3.619

Review 3.  Nociceptin effects in the airways.

Authors:  C Peiser; B J Undem; A Fischer
Journal:  Peptides       Date:  2000-07       Impact factor: 3.750

Review 4.  Nociceptin/orphanin FQ and neurotransmitter release in the central nervous system.

Authors:  E Schlicker; M Morari
Journal:  Peptides       Date:  2000-07       Impact factor: 3.750

5.  Antitussive action of nociceptin in the cat.

Authors:  D C Bolser; R L McLeod; D B Tulshian; J A Hey
Journal:  Eur J Pharmacol       Date:  2001-10-26       Impact factor: 4.432

6.  Urodynamic and clinical evidence of acute inhibitory effects of intravesical nociceptin/orphanin FQ on detrusor overactivity in humans: a pilot study.

Authors:  M Lazzeri; G Calò; M Spinelli; R Guerrini; P Beneforti; S Sandri; A Zanollo; D Regoli; D Turini
Journal:  J Urol       Date:  2001-12       Impact factor: 7.450

7.  Nociceptin inhibits cough in the guinea-pig by activation of ORL(1) receptors.

Authors:  R L McLeod; L E Parra; J C Mutter; C H Erickson; G J Carey; D B Tulshian; A B Fawzi; A Smith-Torhan; R W Egan; F M Cuss; J A Hey
Journal:  Br J Pharmacol       Date:  2001-03       Impact factor: 8.739

Review 8.  The molecular and behavioral pharmacology of the orphanin FQ/nociceptin peptide and receptor family.

Authors:  J S Mogil; G W Pasternak
Journal:  Pharmacol Rev       Date:  2001-09       Impact factor: 25.468

9.  Pharmacological activation of nociceptin receptors in the nucleus tractus solitarius inhibits baroreceptor reflex in pentobarbital-anesthetized rats.

Authors:  L Mao; J Q Wang
Journal:  Neuroscience       Date:  2000       Impact factor: 3.590

10.  Nociceptin inhibits capsaicin-induced bronchoconstriction in isolated guinea pig lung.

Authors:  M R Corboz; M A Rivelli; R W Egan; D Tulshian; J Matasi; A B Fawzi; L Benbow; A Smith-Torhan; H Zhang; J A Hey
Journal:  Eur J Pharmacol       Date:  2000-08-18       Impact factor: 4.432

View more
  8 in total

1.  Effects of nociceptin/orphanin FQ on rats with cathartic colon.

Authors:  Hai-Yan Li; Xiang Yan; Quan-Lai Xue; Yong-Ning Zhou; Yan Gao; Rui Wang; Yong-Ming Liu; Jun-Tao Ran
Journal:  World J Gastroenterol       Date:  2007-01-07       Impact factor: 5.742

Review 2.  Nociceptin/Orphanin FQ Receptor Structure, Signaling, Ligands, Functions, and Interactions with Opioid Systems.

Authors:  Lawrence Toll; Michael R Bruchas; Girolamo Calo'; Brian M Cox; Nurulain T Zaveri
Journal:  Pharmacol Rev       Date:  2016-03-08       Impact factor: 25.468

Review 3.  Update on anticytokine treatment for asthma.

Authors:  Luca Gallelli; Maria Teresa Busceti; Alessandro Vatrella; Rosario Maselli; Girolamo Pelaia
Journal:  Biomed Res Int       Date:  2013-06-18       Impact factor: 3.411

4.  New Role of Adult Lung c-kit+ Cells in a Mouse Model of Airway Hyperresponsiveness.

Authors:  Giuseppe Spaziano; Donato Cappetta; Konrad Urbanek; Elena Piegari; Grazia Esposito; Maria Matteis; Manuela Sgambato; Gioia Tartaglione; Rosa Russo; Raffaele De Palma; Francesco Rossi; Antonella De Angelis; Bruno D'Agostino
Journal:  Mediators Inflamm       Date:  2016-12-20       Impact factor: 4.711

5.  Theophylline action on primary human bronchial epithelial cells under proinflammatory stimuli and steroidal drugs: a therapeutic rationale approach.

Authors:  Luca Gallelli; Daniela Falcone; Roberto Cannataro; Mariarita Perri; Raffaele Serra; Girolamo Pelaia; Rosario Maselli; Rocco Savino; Giuseppe Spaziano; Bruno D'Agostino
Journal:  Drug Des Devel Ther       Date:  2017-01-23       Impact factor: 4.162

6.  Lung Mesenchymal Stem Cells Ameliorate Elastase-Induced Damage in an Animal Model of Emphysema.

Authors:  Donato Cappetta; Antonella De Angelis; Giuseppe Spaziano; Gioia Tartaglione; Elena Piegari; Grazia Esposito; Loreta Pia Ciuffreda; Angela Liparulo; Manuela Sgambato; Teresa Palmira Russo; Francesco Rossi; Liberato Berrino; Konrad Urbanek; Bruno D'Agostino
Journal:  Stem Cells Int       Date:  2018-03-14       Impact factor: 5.443

7.  Montelukast Improves Symptoms and Lung Function in Asthmatic Women Compared With Men.

Authors:  Renata Esposito; Giuseppe Spaziano; Domenico Giannattasio; Francesco Ferrigno; Angela Liparulo; Antonietta Rossi; Fiorentina Roviezzo; Maurizio Sessa; Maddalena Falciani; Liberato Berrino; Mario Polverino; Francesca Polverino; Bruno D'Agostino
Journal:  Front Pharmacol       Date:  2019-09-24       Impact factor: 5.810

8.  Nociceptin/Orphanin Fq in inflammation and remodeling of the small airways in experimental model of airway hyperresponsiveness.

Authors:  Gioia Tartaglione; Giuseppe Spaziano; Manuela Sgambato; Teresa Palmira Russo; Angela Liparulo; Renata Esposito; Salvatore Mirra; Rosanna Filosa; Fiorentina Roviezzo; Francesca Polverino; Bruno D'Agostino
Journal:  Physiol Rep       Date:  2018-10
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.